contract research organizations
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:organization
|
| gptkbp:alsoKnownAs |
gptkb:CROs
|
| gptkbp:associatedWith |
gptkb:Association_of_Clinical_Research_Organizations_(ACRO)
|
| gptkbp:benefit |
cost reduction
increased efficiency access to expertise |
| gptkbp:growthDriver |
cost pressures in pharma industry
globalization of drug development increasing complexity of clinical trials |
| gptkbp:industry |
medical device industry
biotechnology industry pharmaceutical industry |
| gptkbp:notableClient |
gptkb:government_agency
foundations pharmaceutical companies biotechnology companies medical device companies |
| gptkbp:notableExample |
gptkb:Covance
gptkb:IQVIA gptkb:PPD gptkb:Labcorp_Drug_Development gptkb:Medpace gptkb:Parexel gptkb:Charles_River_Laboratories gptkb:ICON_plc gptkb:Syneos_Health |
| gptkbp:origin |
1970s
|
| gptkbp:purpose |
outsourcing research services
|
| gptkbp:region |
gptkb:Europe
gptkb:North_America gptkb:Asia-Pacific |
| gptkbp:regulates |
gptkb:FDA
gptkb:EMA ICH guidelines |
| gptkbp:service |
biostatistics
data management project management medical writing preclinical research regulatory affairs clinical trial management pharmacovigilance |
| gptkbp:trend |
mergers and acquisitions
decentralized clinical trials adoption of digital technologies expansion into emerging markets |
| gptkbp:市值 |
over $50 billion (2020s)
|
| gptkbp:bfsParent |
gptkb:Pharmaceutical_Sciences
gptkb:EMA_Guidelines |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
contract research organizations
|